Sign in
Not yet recruitingNo phase

A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia

Key facts

Who runs it
Zhonghao Fang
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
500 people, planned
Started
Apr 2026
Expected to end
Dec 2026
Type of study
Observational
Record updated
8 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Age ≥ 18 years old
  • Meet the diagnostic criteria for pneumonia (acute onset + new infiltrates on imaging)
  • Have a positive result from pathogen testing
  • Time from onset to admission ≤ 72 hours (to ensure being in the acute phase of the disease)
  • Sign a written informed consent form
  • A diagnosis of "severe pneumonia" can be made if one of the main criteria or ≥ 3 of the secondary criteria are met
  • Main criteria:
  • ① Tracheal intubation requiring mechanical ventilation
  • ② Need for vasoactive drugs after active fluid resuscitation for septic shock
  • Secondary criteria:
  • Respiratory rate ≥ 30 breaths/min; PaO₂/FiO₂ ≤ 250 mm Hg; Multiple lobe infiltrates; Confusion and/or disorientation ⑤ Blood urea nitrogen ≥ 20 mg/dL; ⑥ Leukopenia (WBC < 4×10⁹/L); Thrombocytopenia (PLT < 100×10⁹/L); Decreased body temperature (central body temperature < 36 ℃) ⑨ Hypotension requiring fluid resuscitation

Who cannot take part

  • Those whose main manifestations are other non-infectious diseases (such as pulmonary edema, lung cancer, pulmonary embolism, etc.); 3) Those whose main diagnosis is active pulmonary tuberculosis, non-infectious interstitial lung disease, etc.; 4) Patients considered not applicable by the researchers
  • 1) Patients with severely lacking medical records

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Pneumonia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Retrospective Analysis of Clinical Characteristics and Prognostic Factors in Hospitalized Pneumonia Patients from April 2023 to April 2026. Background: Pneumonia remains the leading cause of death from infectious diseases in adults worldwide, with an increasingly severe disease burden exacerbated by population aging and the frequent emergence of drug-resistant bacteria; in China, severe pneumonia accounts for a striking 13.58% to 20.05% of hospitalized cases. In recent years, shifts in the pathogen spectrum (e.g., COVID-19, influenza A) and patient demographic characteristics have posed new challenges for clinical management. However, existing studies mostly focus on single pathogens or specific populations (e.g., ICU patients), lacking systematic analyses of the full-disease course characteristics of general hospitalized pneumonia patients. Furthermore, in the post-pandemic era, the clinical phenotypes, treatment responses, and prognostic factors of pneumonia may have evolved, necessitating evidence-based support from real-world data. This study aims to conduct a retrospective analysis to clarify the epidemiological characteristics, etiological distribution, and prognostic factors influencing current hospitalized pneumonia patients, thereby providing a basis for optimizing diagnosis and treatment strategies.

The group in the trial

  • pneumonia

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07574866, who can take part
Record updated
8 May 2026